Mon, 14/02/2011 - 16:51 by Gunjan Mehra
Though February is already here, you still have enough time to file for your income tax and claim an early return thereon, before the rush sets in.
Fri, 31/12/2010 - 15:46 by Brian Orelli
Pfizer (NYSE: PFE) is jumping into the diagnostic business with all four paws. The company announced yesterday that it's purchasing Synbiotics to gain access to its veterinary immunodiagnostics business.
Fri, 31/12/2010 - 06:50 by Brian Orelli
Thu, 30/12/2010 - 11:56 by Rex Moore
The power of dividend investing is pretty well-known these days. Higher-yielding stocks tend to offer higher returns over time than low- or no-yield stocks, according to research from Jeremy Siegel and others. In fact, the 20 best-performing survivor stocks from the original S&P 500 in 1957 are alldividend payers.
Thu, 30/12/2010 - 11:14 by Eric Bleeker
It's been a pretty kind year to stock investors, with the S&P showing a 12.8% gain in 2010. Of course, kindness might still feel relative after a lost decade of negative returns that included the nauseating depths and panic of the financial crisis.
Wed, 29/12/2010 - 10:55 by Morgan Housel
I'm a long-term optimist. You should be, too. But even when you're an optimist, a healthy amount of skepticism -- maybe even pessimism -- can do you good. It makes you a more stable optimist.
Fri, 24/12/2010 - 10:59 by Dan Caplinger
Anybody can make money when stocks are going up, and if you know how to sell stocks short, you can profit when stocks drop, too. But what the heck are you supposed to do in a flat market?
Fri, 24/12/2010 - 10:55 by Dan Caplinger
After the big losses of 2008 and early 2009, investors were in a serious hurry to earn back the money they lost. That created a perfect environment for companies offering leveraged exchange-traded funds, which promise amplified returns from market movements in either direction. Even now, leveraged ETFs are still popular, as speculators try to guess the market's next big move.
Thu, 23/12/2010 - 09:47 by Roger Friedman
In our ongoing series of chats with Fool analysts and advisors, I've been asking them about the stocks on their watchlists and the catalysts that would induce them to buy. Today, the man in charge of training our analysts provides two excellent companies that he owns and believes deserve strong consideration for a spot in your portfolio – no catalyst required.
Wed, 22/12/2010 - 10:08 by Matt Koppenheffer
Investors want dividends these days. Maybe it's a fad, maybe it isn't. Either way, I think it's a good thing as long as it lasts. Dividends have historically treated investors very well because they: